• Home
  • Authors Bio
  • The Book
    • The Origin of Disease
  • Excerpt
  • Reviews
  • Gallery
  • Other Works
  • Contact
  • Blog
  • Order Now

07 May

Currently available drugs may help in covid-19 patients

Carolyn Merchant Blog 0 0

We previously suggested we already have many drugs on the market that could help covid-19 patients. Zithromax reduces inflammation and aids in preventing cytokine storms in influenza and covid-19 (3/30/20 post). Numerous anti-parasitics are available, including imervectin, which was shown in the laboratory to stop replication of covid-19, but not yet tested in clinical trials (4/5/20 post). Viral RNA is a string of dead proteins, that use energy from the host cell to replicate—viruses are intracellular parasites that cannot live without a host cell. Treating host pathogens can deprive the virus of the energy needed to replicate; however, underlying host pathogens may differ between patients. Now another antibiotic has been suggested for covid-19 patients, a drug which has been found beneficial in many chronic diseases.
 
Doxycyline treats many forms of chlamydia, including chlamydia pneumonia, chlamydia trachoma, and chlamydia psittacosis. Doxycyline may be particularly beneficial in patients infected with the L-strain of covid-19, because the L-strain likely evolved in Italy, through intracellular reassortment of RNA in combination with intracellular psittacosis (5/6/20 post). Doxycyline or azithromax may help cardiac patients, because most cardiac patients have chronic chlamydia penumonia. Doxycyline and azithromax are available, at a low cost, in both oral tablets and IV, and have a long history of safety. (Doxycycline should not be used in pregnant women, and zithromax is used to treat psittacosis in pregnancy.)
 
These drugs could potentially prevent severe cases of covid-19 if given earlier in the course of the disease, alone, or in combination with anti-parasitics and/or antiviral drugs. If doxycycline or any other currently available drugs are shown effective in reducing morbidity and mortality in covid-19, and are used early in the course of the disease, knowledge that we have an effective treatment would significantly reduce the stress in the population about getting covid-19.
 
https://accpjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2395

chronic disease viruses
Facebook

About the Author

Written by Carolyn Merchant

https://www.youtube.com/watch?v=WbG6mzYUnyU&feature=youtu.be&fbclid=IwAR07cSRiUzBpr1LyW6_XXDtifWuQI9z0N3RTdP37Hv9HXv6oyu1qvRAe1gg


Leave a Reply Cancel reply

Your email address will not be published.

Recent Posts

  • Streptococcus and/or mycoplasma in multiple myeloma?
  • Early treatment of infectious pathogens may aid in preventing chronic disease
  • A new paradigm for chronic disease is needed
  • Follow the clues, considering all abnormal findings
  • Chronic infection = chronic disease

Recent Comments

  • free rm30 online casino on Viruses can infect bacteria
  • learn more on Viruses can infect bacteria
  • Haydee Maceachern on Transmission of chlamydia from animals to humans
  • Malinda Bullis on Lymphoma and psittacosis
  • Free Proxies Socks 5 on Lymphoma and psittacosis

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018

Categories

  • Blog

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Tags

Alzheimer's Alzheimer's disease Animals antibiotics arthritis autism autoimmune Cancer cardiovascular disease Chlamydia chronic disease chronic infection diabetes diagnosis eye disease Eyes gastrointestinal gastrointestinal disease Genetic disease H-pylori H-pylori family Heart disease Inflammation Influenza Medical devices Medical history Medical research Mental health mental illness multiple sclerosis neurologic disease Parasites parkinson's psittacosis reproductive reproductive disease skin Specialization Theory of disease toxoplasmosis trachoma treatment treatments viruses vision


  • Home
  • Authors Bio
  • The Book
  • Excerpt
  • Reviews
  • Gallery
  • Other Works
  • Contact
  • Blog
  • Order Now

Copyright © 2018. Carolyn Merchant, JD & Christopher Merchant, MD. All rights reserved.